Many 340B Providers May Not Pass On Discounts Through Contract Pharmacies – GAO
House Energy and Commerce Committee releases US Government Accountability Office analysis of 340B contract pharmacies.
You may also be interested in...
Energy & Commerce Health Subcommittee releases several discussion drafts at hearing on 340B drug discount program reform as the debate seems poised to move into the next phase.
Third US Senate committee hearing on 340B reforms focuses on the need for legislation requiring that providers report the drug discounts received and how they use the savings, but prospects for achieving change are unclear.
House Energy & Commerce Committee recommends more oversight of hospital participation in the 340B drug discount program.